Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’), is pleased to announce a non-binding Letter of Intent (LOI) with...
Read moreForward Water Technologies Corp. (TSXV: FWTC) (‘ FWTC ‘) and Fraser Mackenzie Accelerator Corp. (TSXV: FMAC.P) (the ‘ FMAC ‘)...
Read moreBrightstar Resources Limited (ASX: BTR) (Brightstar or the Company) is pleased to announce the second round of non- priority assay...
Read moreRadiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of...
Read moreDescription The securities of Elixir Energy Limited (‘EXR’) will be placed in trading halt at the request of EXR, pending...
Read moreGrande Portage Resources Ltd. (TSXV:GPG)(OTCQB:GPTRF)(FSE:GPB)(‘Grande Portage’ or the ‘Company’) is pleased to report that it has filed an updated technical...
Read moreSpeaking on the sidelines of the Rule Symposium, Brent Cook, founder of Exploration Insights, shared his thoughts on the resource...
Read moreGiven that inflation remains an issue for miners, he’s focusing on small gold royalty companies. ‘That’s what I’ve been trying...
Read moreA report published by S&P Global Market Intelligence reveals that the US lags significantly behind other countries in mine development...
Read moreGTI Energy Ltd (GTI or Company) is pleased to provide an update on the upcoming resource expansion drilling program at...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved